Daphne Koller Wants to Fix Drug Discovery With A.I.—and Real Data
Daphne Koller, founder and CEO of Insitro, has established herself as one of the most influential leaders in A.I.-powered drug discovery, earning recognition on this year’s A.I. Power Index. After co-founding and leading Coursera to democratize education globally, Koller pivoted to tackle one of science’s most complex challenges: transforming pharmaceutical research through artificial intelligence. Under…

